Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance).

Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance). Pharmacogenet Genomics. 2021 12 01; 31(9):215-220.

View in: PubMed

subject areas

Antineoplastic Combined Chemotherapy Protocols
Cisplatin
Epirubicin
Fluorouracil
Humans
Leucovorin
Pharmacogenomic Testing
Stomach Neoplasms
X-ray Repair Cross Complementing Protein 1

authors with profiles

Mark J. Ratain